New evidences for a role of mGluR7 in astrocyte survival: Possible implications for neuroprotection. (October 2018)

• Record Type: Journal Article
• Authors: Jantas, Danuta; Lech, Tomasz; Gołda, Sławomir; Pilc, Andrzej; Lasoń, Władysław
• Is Part Of: Neuropharmacology. Volume 141(2018)
• Page Start: 223
• Page End: 237
• Publication Date: 2018-10
• Subjects: AMN082 -- Glia -- Staurosporine -- Doxorubicin -- Glutamate -- U0126 -- LY294002; Neuropsychopharmacology -- Periodicals; Autonomic Agents -- Periodicals; Neuropsychopharmacologie -- Périodiques; Neuropsychopharmacology; Periodicals; Electronic journals; 615.78
• DOI: 10.1016/j.neuropharm.2018.08.035
• Languages: English
• ISSNs: 0028-3908

Abstract

Abstract: A specific activation of metabotropic glutamate receptor 7 (mGluR7) has been shown to be neuroprotective in various models of neuronal cell damage, however, its role in glia cell survival has not been studied, yet. Thus, we performed comparative experiments estimating protective effects of the mGluR7 allosteric agonist AMN082 in glia, neuronal and neuronal-glia cell cultures against various harmful stimuli. First, the transcript levels of mGluR7 and other subtypes of group II and III mGluRs in cortical neuronal, neuronal-glia and glia cell cultures have been measured by qPCR method. Next, we demonstrated that AMN082 with similar efficiency attenuated the glia cell damage evoked by staurosporine (St) and doxorubicin (Dox). The AMN082-mediated glioprotection was mGluR7-dependent and associated with decreased DNA fragmentation without involvement of caspase-3 inhibition. Moreover, the inhibitors of PI3K/Akt and MAPK/ERK1/2 pathways blocked the protective effect of AMN082. In neuronal and neuronal-glia cell cultures in the model of glutamate (Glu)- but not St-evoked cell damage, we showed a significant glia contribution to mGluR7-mediated neuroprotection. Finally, by using glia and neuronal cells derived from mGluR7+/+ and mGluR7−/− mice we demonstrated a higher cell-damaging effect of St and Dox in mGluR7-deficient glia but not in neurons (cerebellar granule cells). Our present data showed for the first time a glioprotective potential of AMN082 underlain by mechanisms involving the activation of PI3K/Akt and MAPK/ERK1/2 pathways and pro-survival role of mGluR7 in glia cells. These findings together with the confirmed neuroprotective properties of AMN082 justify further research on mGluR7-targeted therapies for various CNS disorders. Highlights: Demonstration of glioprotective effects of an mGluR7 agonist. Developmental- and cell damage-dependent contribution of glia cells to mGluR7-mediated neuroprotection. Evidence that the presence of mGluR7 in glia cells makes them more resistant to apoptotic cell damage.